DiDi Global Change in Accounts Payable 2021-2025 | DIDIY
DiDi Global annual/quarterly change in accounts payable history and growth rate from 2021 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
- DiDi Global change in accounts payable for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- DiDi Global change in accounts payable for the twelve months ending March 31, 2025 was $-0.014B, a 105.39% decline year-over-year.
- DiDi Global annual change in accounts payable for 2024 was $-0.014B, a 105.39% decline from 2023.
- DiDi Global annual change in accounts payable for 2023 was $0.262B, a 255% decline from 2022.
- DiDi Global annual change in accounts payable for 2022 was $-0.169B, a 0.41% decline from 2021.
| DiDi Global Annual Change in Accounts Payable (Millions of US $) |
|
|---|---|
| 2024 | $-14 |
| 2023 | $262 |
| 2022 | $-169 |
| 2021 | $-170 |
| 2020 | $187 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $27.156B | $28.768B |
| DiDi Global Inc. provides mobility technology platform. It offers app-based services across Asia Pacific, Latin America and Africa as well as in Central Asia and Russia, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility as well as auto solutions, food delivery, intra-city freight and financial services. DiDi Global Inc. is based in BEIJING. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $151.946B | 28.18 |
| CVS Health (CVS) | United States | $90.013B | 11.19 |
| Elevance Health (ELV) | United States | $70.256B | 9.45 |
| Cencora (COR) | United States | $57.138B | 19.03 |
| Labcorp Holdings (LH) | United States | $22.916B | 18.22 |
| Natera (NTRA) | United States | $21.976B | 0.00 |
| BioMerieux (BMXMF) | France | $17.991B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.475B | 0.00 |
| ICON (ICLR) | Ireland | $14.507B | 13.96 |
| Medpace Holdings (MEDP) | United States | $12.983B | 34.36 |
| CochLear (CHEOY) | Australia | $12.561B | 0.00 |
| Solventum (SOLV) | United States | $12.531B | 12.93 |
| Viatris (VTRS) | United States | $12.452B | 4.43 |
| Revvity (RVTY) | United States | $10.611B | 18.69 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.386B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $9.321B | 0.00 |
| Avantor (AVTR) | United States | $8.849B | 12.98 |
| Charles River Laboratories (CRL) | United States | $7.799B | 14.80 |
| HealthEquity (HQY) | United States | $7.777B | 34.06 |
| Bausch + Lomb (BLCO) | Canada | $5.172B | 34.79 |
| Sotera Health (SHC) | United States | $4.590B | 25.65 |
| BrightSpring Health Services (BTSG) | United States | $4.106B | 31.32 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.466B | 79.38 |
| Surgery Partners (SGRY) | United States | $2.974B | 37.42 |
| Alignment Healthcare (ALHC) | United States | $2.951B | 0.00 |
| Concentras Parent (CON) | United States | $2.944B | 18.67 |
| Organon (OGN) | United States | $2.407B | 2.62 |
| Premier (PINC) | United States | $2.158B | 20.01 |
| Progyny (PGNY) | United States | $1.955B | 41.35 |
| Ardent Health (ARDT) | United States | $1.849B | 7.14 |
| PACS (PACS) | United States | $1.804B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.623B | 27.47 |
| Pediatrix Medical (MD) | United States | $1.436B | 9.59 |
| Teladoc Health (TDOC) | United States | $1.297B | 0.00 |
| Omada Health (OMDA) | $1.171B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.092B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.965B | 0.00 |
| Embecta (EMBC) | United States | $0.798B | 4.67 |
| AMN Healthcare Services Inc (AMN) | United States | $0.769B | 9.51 |
| CareDx (CDNA) | United States | $0.616B | 11.34 |
| Performant Healthcare (PHLT) | United States | $0.601B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.598B | 102.50 |
| Nutex Health (NUTX) | United States | $0.528B | 7.99 |
| Agilon Health (AGL) | United States | $0.518B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.477B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.475B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 7.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.30 |
| Enhabit (EHAB) | United States | $0.409B | 26.87 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.392B | 0.00 |
| So-Young (SY) | China | $0.376B | 0.00 |
| Oncology Institute (TOI) | United States | $0.341B | 0.00 |
| LifeMD (LFMD) | United States | $0.290B | 0.00 |
| Beauty Health (SKIN) | United States | $0.274B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.189B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.124B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.085B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.040B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.035B | 0.00 |
| ModivCare (MODV) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |